NCT06919991View on ClinicalTrials.gov

Drug-Drug Interaction Study of Casdatifan in Healthy Adult Participants (ARC-29)

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

May 2, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2025

Conditions
Healthy Participants
Interventions
DRUG

Casdatifan

Administered as a single dose in treatment Periods 1, 2, and 3

DRUG

Itraconazole

Administered as multiple doses in treatment Period 2

DRUG

Phenytoin

Administered as multiple doses in treatment Period 3

Trial Locations (1)

85283

Celerion, Tempe

Sponsors
All Listed Sponsors
lead

Arcus Biosciences, Inc.

INDUSTRY